# DESCRIPTION

## TECHNICAL FIELD

- relate to method of detecting soluble amyloid β precursor protein 770β

## BACKGROUND ART

- introduce Alzheimer's disease
- describe Aβ production mechanism
- discuss limitations of current diagnostic methods
- highlight importance of CAA diagnosis
- summarize current understanding of APP and Aβ

## SUMMARY OF THE INVENTION

### Problems to be Solved by the Invention

- identify need for early diagnosis method

### Means of Solving the Problems

- focus on Aβ accumulation in cerebral blood vessels
- identify unique splicing variant APP770
- detect cleavage product of APP770
- use sAPP770β as biomarker
- describe method of detecting sAPP770β
- provide variations of detection method
- describe diagnostic reagent and kit
- highlight advantages of detection method
- discuss potential applications
- summarize invention

### Effect of the Invention

- highlight benefits of detection method

## DESCRIPTION OF EMBODIMENTS

### Definition

- define amyloid β precursor protein (APP)
- describe APP splicing variants
- explain soluble amyloid β precursor protein β (sAPPβ)
- define endothelial cell
- define antibody and disease accompanied by Aβ accumulation

### 1. Detection Method of Soluble Amyloid β Precursor Protein 770β

- introduce detection method
- describe step (1) of contacting biological sample with antibody
- specify test subject and biological sample
- describe antibody preparation
- define APP770-specific antibody
- describe antibody recognizing soluble amyloid β precursor protein β
- introduce step (2) of detecting soluble amyloid β precursor protein 770β
- describe optional step (3) of contacting biological sample with antibody
- define sAPP695β-specific antibody
- describe optional step (4) of detecting soluble amyloid β precursor protein 695β
- introduce antibody fragments and binding fragments
- describe labeling of antibodies
- describe conjugation of antibodies to solid phase
- specify contact conditions
- describe detection methods
- introduce detection of sAPP695β and sAPP751β
- describe detection based on molecular weight
- describe detection utilizing mass spectrometer
- determine disease diagnosis based on detection results
- outline detection method of soluble amyloid β precursor protein 770β
- describe step (1) of contacting complex with antibody
- describe step (2a) of labeling antibody
- describe step (2b) of detecting complex
- explain detection methods (EIA, FIA, immunochromatography, Western blotting)
- detail sandwich ELISA method
- describe avidin-biotin reaction method
- describe method using secondary antibody
- explain FIA method
- explain immunochromatography method
- explain Western blotting method
- describe detection of sAPP695β and sAPP751β
- explain quantification of sAPP770β
- describe diagnosis using detection method
- outline alternative detection method II

### 2. Diagnostic Reagent for Disease Accompanied by Accumulation of Amyloid β Peptide

- define diagnostic reagent composition
- describe diagnostic method using reagent

### 3. Kit for Diagnosis of Disease Accompanied by Accumulation of Amyloid β Peptide

- define kit composition
- describe kit usage and forms

## EXAMPLES

- describe examples of the present invention

### (Materials)

- list sources of materials used in the study

### (Expression Plasmid and Cell Culture)

- describe construction of human APP770 FLAG-pEF and cell culture methods

### (Patients and Sample)

- describe patient and sample used in the study

### (PCR Analysis of APP Transcript)

- describe PCR analysis of APP transcript

### (Immunohistochemistry)

- describe immunohistochemistry method

### (Western Blotting)

- describe Western blotting method

### (Quantification of Aβ)

- describe quantification of Aβ40 and Aβ42

### (Biotinylation of Cell Surface)

- describe biotinylation of cell surface

### Example 1

- introduce cell type-specific expression of APP isoforms
- describe Western blot analysis of BMEC
- analyze APP transcript by PCR
- confirm cell type-specific APP expression
- describe expression of APP770 in endothelial cells
- analyze APP expression in HUVEC
- describe processed form of APP or sAPP
- analyze APP expression in neuron
- confirm cell type-specific APP expression

## INDUSTRIAL APPLICABILITY

- describe industrial applicability of the present invention

